Amir Alavi

FDA investigator · also recorded as Ace Ah Amir Alavi

Appears on 9 documents from 2017 to 2024, mostly at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

9
Documents on file
8.0
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 70 observations

Activity by year

2017: 2, 2019: 2, 2021: 2, 2023: 1, 2024: 2

Where

California 5 · Florida 1 · Italy 1 · Puerto Rico 1 · Taiwan 1

Is Amir Alavi coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Baxter Healthcare CorporationJul 19, 2024 · Jayuya, Puerto Rico
483 Nang Kuang Pharmaceutical Co. Ltd.Apr 2, 2024 · Tainan City, Taiwan
483 K.C. Pharmaceuticals, IncFeb 13, 2023 · Pomona, California
483 Teva Parenteral Medicines, Inc.Aug 20, 2021 · Irvine, California
483 Ajinomoto Althea, Inc.May 25, 2021 · San Diego, California
483 Atlas Analytical IncNov 14, 2019 · Brooksville, Florida
483 Teva Parenteral Medicines, Inc.Jan 18, 2019 · Irvine, California

About this profile

What does Amir Alavi inspect?

Amir Alavi appears on 9 documents on file covering 8 sites, mostly in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.165 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Amir Alavi is dated Jul 19, 2024.